Current understanding of the mechanism of benzene-induced leukemia in humans: Implications for risk assessment

Carcinogenesis

Volumn 33, Issue 2, 2012, Pages 240-252

  Mchale, Cliona M ^a   Zhang, Luoping ^a   Smith, Martyn T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BENZOQUINONE; ALKYLATING AGENT; AROMATIC HYDROCARBON RECEPTOR; BENZENE; CCAAT ENHANCER BINDING PROTEIN ALPHA; CD135 ANTIGEN; CYTOCHROME P450; CYTOCHROME P450 2E1; GLYCOPHORIN A; GYRASE INHIBITOR; HYDROQUINONE; MELANOMA ANTIGEN 1; NUCLEOPHOSMIN; OXEPINE DERIVATIVE; PHENOL; PROTEIN P15; PROTEIN P53; RAS PROTEIN; TRANSCRIPTION FACTOR RUNX1;

ACUTE GRANULOCYTIC LEUKEMIA; ANEUPLOIDY; APOPTOSIS; ARTICLE; BLOOD TOXICITY; CANCER RISK; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CHROMOSOME 11Q; CHROMOSOME 15Q; CHROMOSOME 16Q; CHROMOSOME 17; CHROMOSOME 17Q; CHROMOSOME 21; CHROMOSOME 21Q; CHROMOSOME 22; CHROMOSOME 5; CHROMOSOME 6; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME 9; CHROMOSOME ABERRATION; CLONAL EVOLUTION; DNA DAMAGE; DNA METHYLATION; DNA REPAIR; DRUG METABOLISM; EPIGENETICS; EXPOSURE; GENE EXPRESSION; GENE INDUCTION; GENE MUTATION; GENOMIC INSTABILITY; GENOTOXICITY; GENOTYPE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOSURVEILLANCE; IONIZING RADIATION; LEUKEMIA; LEUKEMOGENESIS; MONOSOMY; MYELODYSPLASTIC SYNDROME; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RADIATION INJURY; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STROMA CELL; SYSTEMS BIOLOGY; TAUTOMER; TOXICOGENETICS; TRISOMY;

EID: 84863011500     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr297     Document Type: Article

References (215)

1. ATSDR. (2007) Toxicological Profile For Benzene. http://www.atsdr. cdc.gov/toxprofiles/tp3.html. U.S. Department Of Health And Human Services. Agency for Toxic Substances and Disease Registry, Atlanta, GA.
2. NIOSH. (1990) National Occupational Exposure Survey (1981-83). http://www.cdc.gov/noes/noes3/empl0003.html. National Institute for Occupational Safety and Health Cincinnati, OH.
3. Weisel, C.P. (2010) Benzene exposure: an overview of monitoring methods and their findings. Chem. Biol. Interact., 184, 58-66.
4. Wang, L. et al. (2006) Benzene exposure in the shoemaking industry in China, a literature survey, 1978-2004. Regul. Toxicol. Pharmacol., 46, 149-156.
5. Rappaport, S.M. et al. (2009) Evidence that humans metabolize benzene via two pathways. Environ. Health Perspect., 117, 946-952.
6. Wallace, L. (1996) Environmental exposure to benzene: an update. Environ. Health Perspect., 104 (suppl. 6), 1129-1136.
7. Schettgen, T. et al. (2009) A biomarker approach to estimate the daily intake of benzene in non-smoking and smoking individuals in Germany. J. Expo. Sci. Environ. Epidemiol., 20, 427-433.
8. Lan, Q. et al. (2004) Hematotoxicity in workers exposed to low levels of benzene. Science, 306, 1774-1776.
9. Qu, Q. et al. (2002) Hematological changes among Chinese workers with a broad range of benzene exposures. Am. J. Ind. Med., 42, 275-285.
10. Ward, E. et al. (1996) Risk of low red or white blood cell count related to estimated benzene exposure in a rubberworker cohort (1940-1975). Am. J. Ind. Med., 29, 247-257.
11. Zhang, B. (1996) [Investigation of health status in workers exposed to lowlevel benzene]. Zhonghua Yu Fang Yi Xue Za Zhi, 30, 164-166.
12. Schnatter, R.A. et al. (2010) Peripheral blood effects in benzene-exposed workers. Chem. Biol. Interact., 184, 174-181.
13. Swaen, G.M. et al. (2010) Low level occupational benzene exposure and hematological parameters. Chem. Biol. Interact., 184, 94-100.
14. Collins, J.J. et al. (1997) Evaluation of lymphopenia among workers with low-level benzene exposure and the utility of routine data collection. J. Occup. Environ. Med., 39, 232-237.
15. Tsai, S.P. et al. (2004) A hematology surveillance study of petrochemical workers exposed to benzene. Regul. Toxicol. Pharmacol., 40, 67-73.
16. Pesatori, A.C. et al. (2009) Early effects of low benzene exposure on blood cell counts in Bulgarian petrochemical workers. Med. Lav., 100, 83-90.
17. Forrest, M.S. et al. (2005) Discovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzeneexposed workers. Environ. Health Perspect., 113, 801-807.
18. McHale, C.M. et al. (2009) Changes in the peripheral blood transcriptome associated with occupational benzene exposure identified by crosscomparison on two microarray platforms. Genomics, 93, 343-349.
19. McHale, C.M. et al. (2010) Global gene expression profiling of a population exposed to a range of benzene levels. Environ. Health Perspect., 119, 628-634.
20. Bi, Y. et al. (2009) Gene expression in benzene-exposed workers by microarray analysis of peripheral mononuclear blood cells: induction and silencing of CYP4F3A and regulation of DNA-dependent protein kinase catalytic subunit in DNA double strand break repair. Chem. Biol. Interact., 184, 207-211.
21. Vermeulen, R. et al. (2005) Decreased levels of CXC-chemokines in serum of benzene-exposed workers identified by array-based proteomics. Proc. Natl. Acad. Sci. USA. 102, 17041-17046.
22. Joo, W.A. et al. (2004) Proteomic analysis of plasma proteins of workers exposed to benzene. Mutat. Res., 558, 35-44.
23. Zhang, L. et al. (2010) Systems biology of human benzene exposure. Chem. Biol. Interact., 184, 86-93.
24. Bollati, V. et al. (2007) Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res., 67, 876-880.
25. Ji, Z. et al. (2010) A comparison of the cytogenetic alterations and global DNA hypomethylation induced by the benzene metabolite, hydroquinone, with those induced by melphalan and etoposide. Leukemia, 24, 986-991.
26. North, M. et al. (2009) Utilizing functional genomics in yeast to discover novel biomarkers of benzene toxicity in humans. Toxicol. Lett., 189Abstracts of the 46th Congress of the European Societies of Toxicology, S93.
27. Galvan, N. et al. (2008) Depletion of WRN enhances DNA damage in HeLa cells exposed to the benzene metabolite, hydroquinone. Mutat. Res., 649, 54-61.
28. Ren, X. et al. (2009) Werner syndrome protein, WRN, protects cells from DNA damage induced by the benzene metabolite hydroquinone. Toxicol. Sci., 107, 367-375.
29. Lan, Q. et al. (2009) Large-scale evaluation of candidate genes identifies associations between DNA repair and genomic maintenance and development of benzene hematotoxicity. Carcinogenesis, 30, 50-58.
30. Lan, Q. et al. (2005) Polymorphisms in cytokine and cellular adhesion molecule genes and susceptibility to hematotoxicity among workers exposed to benzene. Cancer Res., 65, 9574-9581.
31. Shen, M. et al. (2006) Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut. Hum. Genet., 119, 659-668.
32. Hosgood, H.D. III et al. (2009) Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. Occup. Environ. Med., 66, 848-853.
33. Sun, P. et al. (2009) Association of genetic polymorphisms, mRNA Expression of p53 and p21 with chronic benzene Poisoning in a Chinese occupational population. Cancer Epidemiol. Biomarkers Prev., 18, 1821-1828.
34. Wu, F. et al. (2008) Genetic polymorphisms in hMTH1, hOGG1 and hMYH and risk of chronic benzene poisoning in a Chinese occupational population. Toxicol. Appl. Pharmacol., 233, 447-453.
35. Sun, P. et al. (2008) Polymorphisms in phase I and phase II metabolism genes and risk of chronic benzene poisoning in a Chinese occupational population. Carcinogenesis, 29, 2325-2329.
36. Zhang, Z. et al. (2005) Genetic polymorphisms in XRCC1, APE1, ADPRT, XRCC2, and XRCC3 and risk of chronic benzene poisoning in a Chinese occupational population. Cancer Epidemiol. Biomarkers Prev., 14, 2614-2619.
37. Zhang, L. et al. (2005) Use of OctoChrome fluorescence in situ hybridization to detect specific aneuploidy among all 24 chromosomes in benzeneexposed workers. Chem. Biol. Interact., 153-154, 117-122.
38. Zhang, L. et al. (2011) Chromosome-wide aneuploidy study (CWAS) in workers exposed to an established leukemogen, benzene. Carcinogenesis, 32, 605-612.
39. Khalade, A. et al. (2010) Exposure to benzene at work and the risk of leukemia: a systematic review and meta-analysis. Environ. Health, 9, 31
40. Smith, M.T. (2010) Advances in understanding benzene health effects and susceptibility. Annu. Rev. Public Health, 31, 133-148.
41. Steinmaus, C. et al. (2008) Meta-analysis of benzene exposure and non-Hodgkin lymphoma: biases could mask an important association. Occup. Environ. Med., 65, 371-378.
42. Eden, T. (2010) Aetiology of childhood leukaemia. Cancer Treat. Rev., 36, 286-297.
43. Galbraith, D. et al. (2010) Benzene and human health: a historical review and appraisal of associations with various diseases. Crit. Rev. Toxicol., 40 (suppl. 2), 1-46.
44. Pyatt, D. (2004) Benzene and hematopoietic malignancies. Clin. Occup. Environ. Med., 4, 529-555, vii.
45. Natelson, E.A. (2007) Benzene-induced acute myeloid leukemia: a clinician's perspective. Am. J. Hematol., 82, 826-830.
46. Godley, L.A. et al. (2008) Therapy-related myeloid leukemia. Semin. Oncol., 35, 418-429.
47. Rowley, J.D. et al. (1981) Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease. Blood, 58, 759-767.
48. Smith, S.M. et al. (2003) Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood, 102, 43-52.
49. Pedersen-Bjergaard, J. et al. (1987) Cytogenetic characteristics of therapyrelated acute nonlymphocytic leukaemia, preleukaemia and acute myeloproliferative syndrome: correlation with clinical data for 61 consecutive cases. Br. J. Haematol., 66, 199-207.
50. Zhang, Y. et al. (2006) Chromatin structural elements and chromosomal translocations in leukemia. DNA Repair (Amst.), 5, 1282-1297.
51. Pedersen-Bjergaard, J. et al. (2008) Genetics of therapy-related myelodysplasia and acute myeloid leukemia. Leukemia, 22, 240-248.
52. Pedersen-Bjergaard, J. et al. (2006) Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia. Leukemia, 20, 1943-1949.
53. Nishikawa, T. et al. (2011) Benzene induces cytotoxicity without metabolic activation. J. Occup. Health, 11, 11
54. Ross, D. (2000) The role of metabolism and specific metabolites in benzene-induced toxicity: evidence and issues. J. Toxicol. Environ. Health, 61, 357-372.
55. Sammett, D. et al. (1979) Partial hepatectomy reduces both metabolism and toxicity of benzene. J. Toxicol. Environ. Health, 5, 785-792.
56. Valentine, J.L. et al. (1996) Reduction of benzene metabolism and toxicity in mice that lack CYP2E1 expression. Toxicol. Appl. Pharmacol., 141, 205-213.
57. Andrews, L.S. et al. (1977) Effects of toluene on the metabolism, disposition and hemopoietic toxicity of [3H]benzene. Biochem. Pharmacol., 26, 293-300.
58. Wetmore, B.A. et al. (2008) Genotoxicity of intermittent co-exposure to benzene and toluene in male CD-1 mice. Chem. Biol. Interact., 173, 166-178.
59. Bird, M.G. et al. (2010) Influence of toluene co-exposure on the metabolism and genotoxicity of benzene in mice using continuous and intermittent exposures. Chem. Biol. Interact., 184, 233-239.
60. Snyder, R. et al. (1996) An overview of benzene metabolism. Environ. Health Perspect., 104 (suppl. 6), 1165-1171.
61. Powley, M.W. et al. (2002) Benzene metabolism by the isolated perfused lung. Inhal. Toxicol., 14, 569-584.
62. Sheets, P. et al. (2004) Kinetic factors involved in the metabolism of benzene in mouse lung and liver. J. Toxicol. Environ. Health A, 67, 421-430.
63. Andrews, L.S. et al. (1979) 3H-Benzene metabolism in rabbit bone marrow. Life Sci., 25, 567-572.
64. Irons, R.D. et al. (1980) Benzene is metabolized and covalently bound in bone marrow in situ. Chem. Biol. Interact., 30, 241-245.
65. Subrahmanyam, V.V. et al. (1990) Phenol-induced stimulation of hydroquinone bioactivation in mouse bone marrow in vivo: possible implications in benzene myelotoxicity. Toxicology, 62, 107-116.
66. Subrahmanyam, V.V. et al. (1991) Hydroxylation of phenol to hydroquinone catalyzed by a human myeloperoxidase-superoxide complex: possible implications in benzene-induced myelotoxicity. Free Radic. Res. Commun., 15, 285-296.
67. Nedelcheva, V. et al. (1999) Metabolism of benzene in human liver microsomes: individual variations in relation to CYP2E1 expression. Arch. Toxicol., 73, 33-40.
68. Powley, M.W. et al. (2000) Cytochromes P450 involved with benzene metabolism in hepatic and pulmonary microsomes. J. Biochem. Mol. Toxicol., 14, 303-309.
69. Koskela, S. et al. (1999) Expression of CYP2A genes in human liver and extrahepatic tissues. Biochem. Pharmacol., 57, 1407-1413.
70. Su, T. et al. (2000) Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res., 60, 5074-5079.
71. Rappaport, S.M. et al. (2009) Human benzene metabolism following occupational and environmental exposures. Chem. Biol. Interact., 184, 189-195.
72. Inoue, O. et al. (1989) Excretion of 1,2,4-benzenetriol in the urine of workers exposed to benzene. Br. J. Ind. Med., 46, 559-565.
73. Witz, G. et al. (1996) Reactive ring-opened aldehyde metabolites in benzene hematotoxicity. Environ. Health Perspect., 104 (suppl. 6), 1195-1199.
74. Smith, M.T. (1996) The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia. Environ. Health Perspect., 104 (suppl. 6), 1219-1225.
75. Subrahmanyam, V.V. et al. (1991) Potential role of free radicals in benzene-induced myelotoxicity and leukemia. Free Radic. Biol. Med., 11, 495-515.
76. Iskander, K. et al. (2005) Quinone oxidoreductases in protection against myelogenous hyperplasia and benzene toxicity. Chem. Biol. Interact., 153-154, 147-157.
77. Long, D.J. II et al. (2002) Disruption of the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene in mice causes myelogenous hyperplasia. Cancer Res., 62, 3030-3036.
78. Rothman, N. et al. (1997) Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C->T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res., 57, 2839-2842.
79. Irons, R.D. et al. (1993) Cell proliferation and differentiation in chemical leukemogenesis. Stem Cells, 11, 235-242.
80. Bratton, S.B. et al. (1997) Identification of quinol thioethers in bone marrow of hydroquinone/phenol-treated rats and mice and their potential role in benzene-mediated hematotoxicity. Chem. Res. Toxicol., 10, 859-865.
81. Monks, T.J. et al. (2010) The fate of benzene-oxide. Chem. Biol. Interact., 184, 201-206.
82. Ross, D. et al. (2010) Relationships between metabolic and non-metabolic susceptibility factors in benzene toxicity. Chem. Biol. Interact., 184, 222-228.
83. Mansi, A. et al. (2011) Low occupational exposure to benzene in a petrochemical plant: modulating effect of genetic polymorphisms and smoking habit on the urinary t, t-MA/SPMA ratio. Toxicol. Lett., 15, 15
84. Bogadi-Soare, A. et al. (1997) Genotoxic effects in workers exposed to benzene: with special reference to exposure biomarkers and confounding factors. Ind. Health, 35, 367-373.
85. Ding, X.J. et al. (1983) Chromosome changes in patients with chronic benzene poisoning. Chin. Med. J. (Engl.), 96, 681-685.
86. Forni, A.M. et al. (1971) Chromosome changes and their evolution in subjects with past exposure to benzene. Arch. Environ. Health, 23, 385-391.
87. Kasuba, V. et al. (2000) Cytogenetic changes in subjects occupationally exposed to benzene. Chemosphere, 40, 307-310.
88. Picciano, D. (1979) Cytogenetic study of workers exposed to benzene. Environ. Res., 19, 33-38.
89. Sasiadek, M. (1992) Nonrandom distribution of breakpoints in the karyotypes of workers occupationally exposed to benzene. Environ. Health Perspect., 97, 255-257.
90. Sasiadek, M. et al. (1990) Genotoxic effects observed in workers occupationally exposed to organic solvents. Pol. J. Occup. Med., 3, 103-108.
91. Sasiadek, M. et al. (1989) Localization of breakpoints in the karyotype of workers professionally exposed to benzene. Mutat. Res., 224, 235-240.
92. Tompa, A. et al. (1994) Monitoring of benzene-exposed workers for genotoxic effects of benzene: improved-working-condition-related decrease in the frequencies of chromosomal aberrations in peripheral blood lymphocytes. Mutat. Res., 304, 159-165.
93. Tough, I.M. et al. (1965) Chromosome aberrations and exposure to ambient benzene. Lancet, 1, 684
94. Tough, I.M. et al. (1970) Chromosome studies on workers exposed to atmospheric benzene. The possible influence of age. Eur. J. Cancer, 6, 49-55.
95. Yardley-Jones, A. et al. (1990) Analysis of chromosomal aberrations in workers exposed to low level benzene. Br. J. Ind. Med., 47, 48-51.
96. Zhang, L. et al. (1998) Increased aneusomy and long arm deletion of chromosomes 5 and 7 in the lymphocytes of Chinese workers exposed to benzene. Carcinogenesis, 19, 1955-1961.
97. Zhang, L. et al. (2007) Aberrations in chromosomes associated with lymphoma and therapy-related leukemia in benzene-exposed workers. Environ. Mol. Mutagen., 48, 467-474.
98. Zhang, L. et al. (2002) The nature of chromosomal aberrations detected in humans exposed to benzene. Crit. Rev. Toxicol., 32, 1-42.
99. Smith, M.T. et al. (1998) Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene. Cancer Res., 58, 2176-2181.
100. Zhang, L. et al. (1999) Benzene increases aneuploidy in the lymphocytes of exposed workers: a comparison of data obtained by fluorescence in situ hybridization in interphase and metaphase cells. Environ. Mol. Mutagen., 34, 260-268.
101. Smith, M.T. et al. (2000) Hydroquinone, a benzene metabolite, increases the level of aneusomy of chromosomes 7 and 8 in human CD34-positive blood progenitor cells. Carcinogenesis, 21, 1485-1490.
102. Stillman, W.S. et al. (2000) The benzene metabolite, hydroquinone, selectively induces 5q31- and -7 in human CD34{thorn}CD19- bone marrow cells. Exp. Hematol., 28, 169-176.
103. Forni, A. (1966) Chromosome changes due to chronic exposure to benzene. International Congress on Occupational Health, Vienna, Australia, pp. 437-439.
104. Li, Y. et al. (1990) Chromosome changes by G-banding in patients with chronic benzene poisoning. Chinese J. Ind. Med., 3, 29-31.
105. Kim, Y.J. et al. (2010) Micronucleus-centromere assay in workers occupationally exposed to low level of benzene. Hum. Exp. Toxicol., 29, 343-350.
106. Irons, R.D. (1985) Quinones as toxic metabolites of benzene. J. Toxicol. Environ. Health, 16, 673-678.
107. Zhang, L. et al. (1994) Detection of 1,2,4-benzenetriol induced aneuploidy and microtubule disruption by fluorescence in situ hybridization and immunocytochemistry. Mutat. Res., 320, 315-327.
108. Eastmond, D.A. et al. (2001) Characterization and mechanisms of chromosomal alterations induced by benzene in mice and humans. Res. Rep. Health Eff. Inst., 103, 1-68; discussion, 69-80.
109. Lindsey, R.H. Jr et al. (2005) Effects of benzene metabolites on DNA cleavage mediated by human topoisomerase II alpha: 1,4-hydroquinone is a topoisomerase II poison. Chem. Res. Toxicol., 18, 761-770.
110. Chen, H. et al. (1995) Topoisomerase inhibition by phenolic metabolites: a potential mechanism for benzene's clastogenic effects. Carcinogenesis, 16, 2301-2307.
111. Frantz, C.E. et al. (1996) Inhibition of human topoisomerase II in vitro by bioactive benzene metabolites. Environ. Health Perspect., 104 (suppl. 6), 1319-1323.
112. Hutt, A.M. et al. (1996) Inhibition of human DNA topoisomerase II by hydroquinone and p-benzoquinone, reactive metabolites of benzene. Environ. Health Perspect., 104 (suppl. 6), 1265-1269.
113. Fung, J. et al. (2004) Inhibition of topoisomerase II in 32D.3(G) cells by hydroquinone is associated with cell death. J. Appl. Toxicol., 24, 183-188.
114. Lindsey, R.H.Jr. et al. (2004) 1,4-Benzoquinone is a topoisomerase II poison. Biochemistry, 43, 7563-7574.
115. Whysner, J. et al. (2004) Genotoxicity of benzene and its metabolites. Mutat. Res., 566, 99-130.
116. Eastmond, D.A. et al. (2005) Topoisomerase II inhibition by myeloperoxidase-activated hydroquinone: a potential mechanism underlying the genotoxic and carcinogenic effects of benzene. Chem. Biol. Interact., 153-154, 207-216.
117. Baker, R.K. et al. (2001) Benzene metabolites antagonize etoposidestabilized cleavable complexes of DNA topoisomerase IIalpha. Blood, 98, 830-833.
118. Pandey, A.K. et al. (2009) In silico studies with human DNA topoisomerase-II alpha to unravel the mechanism of in vitro genotoxicity of benzene and its metabolites. Mutat. Res., 661, 57-70.
119. Ji, Z. et al. (2009) The benzene metabolite, hydroquinone and etoposide both induce endoreduplication in human lymphoblastoid TK6 cells. Mutagenesis, 24, 367-372.
120. Rothman, N. et al. (1995) Benzene induces gene-duplicating but not geneinactivating mutations at the glycophorin A locus in exposed humans. Proc. Natl Acad. Sci. USA, 92, 4069-4073.
121. Rothman, N. et al. (1996) An epidemiologic study of early biologic effects of benzene in Chinese workers. Environ. Health Perspect., 104 (suppl. 6), 1365-1370.
122. Boyse, J. et al. (1996) Glycophorin A mutations and risk of secondary leukaemia in patients treated for childhood acute lymphoblastic leukaemia. Br. J. Haematol., 93, 117-124.
123. Yu, K. et al. (2011) Decreased topoisomerase IIalpha expression and altered histone and regulatory factors of topoisomerase IIalpha promoter in patients with chronic benzene poisoning. Toxicol. Lett., 5, 5
124. Andersen, M.K. et al. (2002) Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer, 33, 395-400.
125. Mistry, A.R. et al. (2005) DNA topoisomerase II in therapy-related acute promyelocytic leukemia. N. Engl. J. Med., 352, 1529-1538.
126. Pedersen-Bjergaard, J. et al. (2007) Genetic pathways in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia. Hematology Am. Soc. Hematol. Educ. Program, 392-397.
127. Voltz, R. et al. (2004) Mitoxantrone therapy in multiple sclerosis and acute leukaemia: a case report out of 644 treated patients. Mult. Scler., 10, 472-474.
128. Schoch, C. et al. (2005) Genomic gains and losses influence expression levels of genes located within the affected regions: a study on acute myeloid leukemias with trisomy 8, 11, or 13, monosomy 7, or deletion 5q. Leukemia, 19, 1224-1228.
129. Kerkel, K. et al. (2010) Altered DNA methylation in leukocytes with trisomy 21 PLoS Genet., 6, e1001212
130. Falini, B. et al. (2007) Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc{thorn} AML): biologic and clinical features. Blood, 109, 874-885.
131. Mardis, E.R. et al. (2009) Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med., 361, 1058-1066.
132. Albertini, R.J. et al. (2010) Hprt mutant frequency and p53 gene status in mice chronically exposed by inhalation to benzene. Chem. Biol. Interact., 184, 77-85.
133. Mullin, A.H. et al. (1995) Inhalation of benzene leads to an increase in the mutant frequencies of a lacI transgene in lung and spleen tissues of mice. Mutat. Res., 327, 121-129.
134. Mullin, A.H. et al. (1998) Inhaled benzene increases the frequency and length of lacI deletion mutations in lung tissues of mice. Carcinogenesis, 19, 1723-1733.
135. Billet, S. et al. (2010) Benzene-induced mutational pattern in the tumour suppressor gene TP53 analysed by use of a functional assay, the functional analysis of separated alleles in yeast, in human lung cells. Arch. Toxicol., 84, 99-107.
136. Petitjean, A. et al. (2007) Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum. Mutat., 28, 622-629.
137. Ho, T.Y. et al. (1997) Increased gene expression in human promyeloid leukemia cells exposed to trans, trans-muconaldehyde, a hematotoxic benzene metabolite. Carcinogenesis, 18, 739-744.
138. Kolachana, P. et al. (1993) Benzene and its phenolic metabolites produce oxidative DNA damage in HL60 cells in vitro and in the bone marrow in vivo. Cancer Res., 53, 1023-1026.
139. Wiemels, J. et al. (1999) Enhancement of myeloid cell growth by benzene metabolites via the production of active oxygen species. Free Radic. Res., 30, 93-103.
140. Winn, L.M. (2003) Homologous recombination initiated by benzene metabolites: a potential role of oxidative stress. Toxicol. Sci., 72, 143-149.
141. Shen, M. et al. (2008) Association between mitochondrial DNA copy number, blood cell counts, and occupational benzene exposure. Environ. Mol. Mutagen., 49, 453-457.
142. Siegel, D. et al. (2004) NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Mol. Pharmacol., 65, 1238-1247.
143. Hartwig, A. (2010) The role of DNA repair in benzene-induced carcinogenesis. Chem. Biol. Interact., 184, 269-272.
144. Xiao, X. et al. (2010) Role of DNA-PKcs in the biological effect of a benzene metabolite: phenol toxicity to human K562 cells in vitro. Chem. Biol. Interact., 184, 302-305.
145. Ishihama, M. et al. (2008) Generation of phosphorylated histone H2AX by benzene metabolites. Toxicol. In Vitro, 22, 1861-1868.
146. Alexander, D. et al. (2010) Differential DNA repair in hematopoietic stem and progenitor cells following genotoxic damage by benzene metabolites. Toxicol. Sci., 114, 29
147. Mohrin, M. et al. (2010) Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell, 7, 174-185.
148. Milyavsky, M. et al. (2010) A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal. Cell Stem Cell, 7, 186-197.
149. Zeng, Y. et al. (2010) High-performance single cell genetic analysis using microfluidic emulsion generator arrays. Anal. Chem., 82, 3183-3190.
150. Guil, S. et al. (2009) DNA methylomes, histone codes and miRNAs: tying it all together. Int. J. Biochem. Cell Biol., 41, 87-95.
151. Shames, D.S. et al. (2007) DNA methylation in health, disease, and cancer. Curr. Mol. Med., 7, 85-102.
152. Esteller, M. et al. (2002) Cancer as an epigenetic disease: dNA methylation and chromatin alterations in human tumours. J. Pathol., 196, 1-7.
153. Baccarelli, A. et al. (2009) Epigenetics and environmental chemicals. Curr. Opin. Pediatr., 21, 243-251.
154. Ren, X. et al. (2011) An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ. Health Perspect., 119, 11-19.
155. Xing, C. et al. (2010) Methylation and expression analysis of tumor suppressor genes p15 and p16 in benzene poisoning. Chem. Biol. Interact., 184, 306-309.
156. Gowans, I.D. et al. (2005) Genotype-dependent induction of transmissible chromosomal instability by gamma-radiation and the benzene metabolite hydroquinone. Cancer Res., 65, 3527-3530.
157. Ren, X. et al. (2011) Comparison of proliferation and genomic instability responses to WRN silencing in hematopoietic HL60 and TK6 cells. PLoS One, 6, e14546
158. Shen, M. et al. (2006) Polymorphisms in genes involved in DNA doublestrand break repair pathway and susceptibility to benzene-induced hematotoxicity. Carcinogenesis, 27, 2083-2089.
159. Sheltzer, J.M. et al. (2011) Aneuploidy drives genomic instability in yeast. Science, 333, 1026-1030.
160. Solomon, D.A. et al. (2011) Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science, 333, 1039-1043.
161. Hirabayashi, Y. et al. (2009) Aryl hydrocarbon receptor biology and xenobiotic responses in hematopoietic progenitor cells. Biochem. Pharmacol., 77, 521-535.
162. Singh, K.P. et al. (2009) The aryl hydrocarbon receptor has a normal function in the regulation of hematopoietic and other stem/progenitor cell populations. Biochem. Pharmacol., 77, 577-587.
163. Westphal, G. et al. (2009) The benzene metabolite para -benzoquinone is genotoxic in human, phorbol-12-acetate-13-myristate induced, peripheral bloodmononuclear cells at low concentrations. Arch. Toxicol., 83, 721-729.
164. Yoon, B.I. et al. (2002) Aryl hydrocarbon receptor mediates benzeneinduced hematotoxicity. Toxicol. Sci, 70, 150-156.
165. Hirabayashi, Y. et al. (2008) Benzene-induced hematopoietic toxicity transmitted by AhR in wild-type mouse and nullified by repopulation with AhR-deficient bone marrow cells: time after benzene treatment and recovery. Chemosphere, 73, S290-S294.
166. Hirabayashi, Y. et al. (2010) Benzene-induced bone-marrow toxicity: a hematopoietic stem-cell-specific, aryl hydrocarbon receptor-mediated adverse effect. Chem. Biol. Interact., 184, 252-258.
167. Gasiewicz, T.A. et al. (2010) The aryl hydrocarbon receptor has an important role in the regulation of hematopoiesis: implications for benzeneinduced hematopoietic toxicity. Chem. Biol. Interact., 184, 246-251.
168. Moran, J.L. et al. (1996) Induction of apoptosis by benzene metabolites in HL60 and CD34{thorn} human bone marrow progenitor cells. Mol. Pharmacol., 50, 610-615.
169. Martínez-Velázquez, M. et al. (2006) Benzene metabolites induce apoptosis in lymphocytes. Exp. Toxicol. Pathol., 58, 65-70.
170. Montecino-Rodriguez, E. et al. (2001) Regulation of hematopoiesis by gap junction-mediated intercellular communication. J Leukoc Biol, 70, 341-347.
171. Ploemacher, R.E. et al. (2000) Hematopoiesis: gap junction intercellular communication is likely to be involved in regulation of stroma-dependent proliferation of hemopoietic stem cells. Hematology, 5, 133-147.
172. Montecino-Rodriguez, E. et al. (2000) Expression of connexin 43 (Cx43) is critical for normal hematopoiesis. Blood, 96, 917-924.
173. Cancelas, J.A. et al. (2000) Connexin-43 gap junctions are involved in multiconnexin-expressing stromal support of hemopoietic progenitors and stem cells. Blood, 96, 498-505.
174. Rivedal, E. et al. (2005) Metabolites of benzene are potent inhibitors of gap-junction intercellular communication. Arch. Toxicol., 79, 303-311.
175. Rivedal, E. et al. (2009) Gap junction intercellular communication and benzene toxicity. Chem. Biol. Interact., 184, 229-232.
176. Yin, T. et al. (2006) The stem cell niches in bone. J. Clin. Invest., 116, 1195-1201.
177. Zhang, J. et al. (2008) Stem cell niche: microenvironment and beyond. J. Biol. Chem., 283, 9499-9503.
178. Lv, L. et al. (2007) The TNF-a 238A polymorphism is associated with susceptibility to persistent bone marrow dysplasia following chronic exposure to benzene. Leuk. Res., 31, 1479-1485.
179. Zhou, H. et al. (2010) NAD(P)H:quinone oxidoreductase 1-compromised human bone marrow endothelial cells exhibit decreased adhesion molecule expression and CD34+ hematopoietic cell adhesion. J. Pharmacol. Exp. Ther., 334, 260-268.
180. Smart, R.C. et al. (1984) DT-diaphorase and peroxidase influence the covalent binding of the metabolites of phenol, the major metabolite of benzene. Mol. Pharmacol., 26, 105-111.
181. Thomas, D.J. et al. (1990) Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid cells. Mol. Pharmacol., 37, 255-262.
182. Zhou, H. et al. (2009) Benzene metabolite hydroquinone up-regulates chondromodulin-I and inhibits tube formation in human bone marrow endothelial cells. Mol. Pharmacol., 76, 579-587.
183. Pervaiz, S. et al. (2009) Oxidative stress regulation of stem and progenitor cells. Antioxid. Redox Signal., 11, 2777-2789.
184. Ghaffari, S. (2008) Oxidative stress in the regulation of normal and neoplastic hematopoiesis. Antioxid. Redox Signal., 10, 1923-1940.
185. Badham, H.J. et al. (2010) In utero exposure to benzene disrupts fetal hematopoietic progenitor cell growth via reactive oxygen species. Toxicol. Sci., 113, 207-215.
186. Badham, H.J. et al. (2010) In utero and in vitro effects of benzene and its metabolites on erythroid differentiation and the role of reactive oxygen species. Toxicol. Appl. Pharmacol., 244, 273-279.
187. Gross, S.A. et al. (2006) PU.1 phosphorylation correlates with hydroquinone-induced alterations in myeloid differentiation and cytokinedependent clonogenic response in human CD34(+) hematopoietic progenitor cells. Cell Biol. Toxicol., 22, 229-241.
188. Butler, J.M. et al. (2010) Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell, 6, 251-264.
189. Di Maggio, N. et al. (2011) Toward modeling the bone marrow niche using scaffold-based 3D culture systems. Biomaterials, 32, 321-329.
190. Au, W.W. et al. (2010) Challenge assay: a functional biomarker for exposure-induced DNA repair deficiency and for risk of cancer. Int. J. Hyg. Environ. Health, 213, 32-39.
191. Shuga, J. et al. (2010) Selected technologies for measuring acquired genetic damage in humans. Environ. Mol. Mutagen., 51, 851-870.
192. Li, B. et al. (2009) Decreased T-cell receptor excision DNA circles in peripheral blood mononuclear cells among benzene-exposed workers. Int. J. Immunogenet., 36, 107-111.
193. Gale, R.P. et al. (2011) Commentary: does immune suppression increase risk of developing acute myeloid leukemia? Leukemia. doi:10.1038/ leu.2011.224
194. Guyton, K.Z. et al. (2009) A reexamination of the PPAR-alpha activation mode of action as a basis for assessing human cancer risks of environmental contaminants. Environ. Health Perspect., 117, 1664-1672.
195. US Environmental Protection Agency (2005) Guidelines for carcinogen risk assessment and supplemental guidance for assessing susceptibility from early-life exposure to carcinogens. Fed. Regist., vol. 70, 17765-17817.
196. Meek, M.E. et al. (2003) A framework for human relevance analysis of information on carcinogenic modes of action. Crit. Rev. Toxicol., 33, 591-653.
197. Boobis, A.R. et al. (2006) IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit. Rev. Toxicol., 36, 781-792.
198. Meek, M.E. et al. (2010) Proposed mode of action of benzene-induced leukemia: interpreting available data and identifying critical data gaps for risk assessment. Chem. Biol. Interact., 184, 279-285.
199. Snyder, C.A. et al. (1980) The inhalation toxicology of benzene: incidence of hematopoietic neoplasms and hematotoxicity in ARK/J and C57BL/6J mice. Toxicol. Appl. Pharmacol., 54, 323-331.
200. Cronkite, E.P. et al. (1989) Hematotoxicity and carcinogenicity of inhaled benzene. Environ. Health Perspect., 82, 97-108.
201. NTP. (2011) Report on Carcinogens. ntp.niehs.nih.gov/ntp/roc/twelfth/profiles/Benzene.pdf, Department of Health and Human Services, Research Triangle Park, NC.
202. Huff, J.E. et al. (1989) Multiple-site carcinogenicity of benzene in Fischer 344 rats and B6C3F1 mice. Environ. Health Perspect., 82, 125-163.
203. NTP. (1986) NTP Toxicology and Carcinogenesis Studies of Benzene (CAS No. 71-43-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Technical Report Series. U.S. Department Of Health And Human Services, Public Health Service, National Institutes of Health Bethesda, MD, Vol. 289, pp. 1-277
204. McHale, C.M. et al. (2010) Toxicogenomic profiling of chemically exposed humans in risk assessment. Mutat. Res., 705, 172-183.
205. Wilson, V.S. et al. (2011) Utilizing toxicogenomic data to understand chemical mechanism of action in risk assessment. Toxicol. Appl. Pharmacol., 2, 2
206. Faiola, B. et al. (2004) Gene expression profile in bone marrow and hematopoietic stem cells in mice exposed to inhaled benzene. Mutat. Res., 549, 195-212.
207. Yoon, B.I. et al. (2003) Mechanisms of benzene-induced hematotoxicity and leukemogenicity: cDNA microarray analyses using mouse bone marrow tissue. Environ. Health Perspect., 111, 1411-1420.
208. Kawasaki, Y. et al. (2009) Benzene-induced hematopoietic neoplasms including myeloid leukemia in Trp53-deficient C57BL/6 and C3H/He mice. Toxicol. Sci., 110, 293-306.
209. Sarma, S.N. et al. (2011) Differential gene expression profiles of human leukemia cell lines exposed to benzene and its metabolites. Environ. Toxicol. Pharmacol., 32, 285-295.
210. Gillis, B. et al. (2007) Identification of human cell responses to benzene and benzene metabolites. Genomics, 90, 324-333.
211. Roeder, I. et al. (2011) Towards a quantitative understanding of stem cellniche interaction: experiments, models, and technologies. Blood Cells Mol. Dis., 46, 308-317.
212. Kobel, S. et al. (2010) High-throughput methods to define complex stem cell niches. Biotechniques, 48, ix-xxii.
213. Peerani, R. et al. (2009) Patterning mouse and human embryonic stem cells using micro-contact printing. Methods Mol. Biol., 482, 21-33.
214. Peerani, R. et al. (2009) Manipulation of signaling thresholds in "engineered stem cell niches" identifies design criteria for pluripotent stem cell screens. PLoS One, 4, e6438
215. Lan, Q. et al. (2006) Benzene exposure and hematotoxicity: response. Science, 312, 998-998.